Autres (96)

¹ Publications considérées comme production de l’unité.

filter_list Type (agr.) Autres

2025

  1. Clinical experience with cranial nerve palsy in patients infused with ciltacabtagene autoleucel for the treatment of relapsed/refractory MM in CARTITUDE-1, -2, and -4

    Blood Cancer Journal

  2. Erratum: Correction to: Dissecting Secondary Immunodeficiency: Identification of Primary Immunodeficiency within B-Cell Lymphoproliferative Disorders (Journal of clinical immunology (2024) 45 1 DOI: 10.1007/s10875-024-01818-2.)

    Journal of clinical immunology

2024

  1. Brain 18F-FDG PET findings and sequential vestibular testing in SCA27B: a case report

    Journal of Neurology

  2. GCN2 inhibition reduces mutant SOD1 clustering and toxicity and delays disease progression in an amyotrophic lateral sclerosis mouse model

    Translational Neurodegeneration

  3. Reply to the letter: Headaches during/after SARS-CoV-2 infection/vaccination can be primary and secondary as well as acute and chronic, by Finsterer J and Mehri S

    European Journal of Neurology

2023

  1. Hemihypomimia in Parkinson’s disease: an under-recognized clinical sign?

    Journal of Neurology

  2. Inequity of access to new migraine treatments

    Neurologia

2022

  1. Home-based transcranial static magnetic field stimulation of the motor cortex for treating levodopa-induced dyskinesias in Parkinson's disease: A randomized controlled trial

    Brain Stimulation

  2. Preoperative Hemoglobin and Actual Need for Blood Transfusion in Brain Tumor Resection Procedures: A Retrospective Cohort Study

    Journal of Neurosurgical Anesthesiology

2021

  1. Author Correction: Epilepsy and neuropsychiatric comorbidities in mice carrying a recurrent Dravet syndrome SCN1A missense mutation (Scientific Reports, (2019), 9, 1, (14172), 10.1038/s41598-019-50627-w)

    Scientific Reports

  2. Machine Learning Will Extend the Clinical Utility of Adaptive Deep Brain Stimulation

    Movement Disorders

  3. Multiple cerebral microbleeds associated with disseminated intravascular coagulation

    Neurologia

  4. Oligodendrocytes, a New Player in the Etiology of Parkinson's Disease

    Movement Disorders

2020

  1. CLIPPERS syndrome: A case report

    Neurologia

  2. Correction to: Motor impulsivity and delay intolerance are elicited in a dose-dependent manner with a dopaminergic agonist in parkinsonian rats (Psychopharmacology, (2020), 237, 8, (2419-2431), 10.1007/s00213-020-05544-6)

    Psychopharmacology

  3. Erratum: A Spanish consensus on the use of safinamide for parkinson’s disease in clinical practice. (Brain sci. (2020) 10, 176)

    Brain Sciences

  4. Genetic epilepsies and COVID-19 pandemic: Lessons from the caregiver perspective

    Epilepsia

  5. Impact of the Coronavirus Disease 2019 Pandemic on Functional Movement Disorders: Lessons From a Specialized Clinic

    Movement Disorders

  6. Validity evidence of SIMUL-Eye: eye movement and pupillary reflex simulator

    Acta Ophthalmologica

2019

  1. Combining gene transfer and nonhuman primates to better understand and treat Parkinson’s disease

    Frontiers in Molecular Neuroscience